ecopipam has been researched along with Cocaine Abuse in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chausmer, AL; Griffiths, RR; Kelly, RY; Smith, BJ | 1 |
| Davidson, C; Ellinwood, EH; Gao, WY; Lee, TH | 1 |
| Clarke, L; Coffin, V; Cornish, J; Glue, P; Kampman, K; Kaplan, HL; O'Brien, CP; Poole, S; Romach, MK; Sellers, EM; Somer, GR | 1 |
| Kosten, TA; Kosten, TR; McCance-Katz, EF | 1 |
| Fischman, MW; Foltin, RW; Haney, M; Ward, AS | 1 |
| Bigelow, GE; Donny, EC; Nann-Vernotica, E; Walsh, SL | 1 |
4 trial(s) available for ecopipam and Cocaine Abuse
| Article | Year |
|---|---|
Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).
Topics: Adult; Benzazepines; Blood Pressure; Cocaine-Related Disorders; Dopamine Antagonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; GABA Modulators; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Nicotine; Pain Measurement; Receptors, Dopamine D1; Time Factors; Triazolam | 2003 |
Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)
Topics: Adult; Behavior, Addictive; Benzazepines; Cocaine; Cocaine-Related Disorders; Dopamine Antagonists; Euphoria; Female; Humans; Male; Receptors, Dopamine; Reward | 1999 |
Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans.
Topics: Administration, Inhalation; Adult; Benzazepines; Cocaine; Cocaine-Related Disorders; Cross-Over Studies; Dopamine Antagonists; Dopamine Uptake Inhibitors; Female; Hemodynamics; Humans; Male; Psychiatric Status Rating Scales; Receptors, Dopamine D1; Self Administration | 2001 |
Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.
Topics: Adult; Benzazepines; Cocaine; Cocaine-Related Disorders; Cross-Over Studies; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Receptors, Dopamine D1; Receptors, Dopamine D5; Smoking; Smoking Cessation; Surveys and Questionnaires | 2001 |
2 other study(ies) available for ecopipam and Cocaine Abuse
| Article | Year |
|---|---|
Altered activity of midbrain dopamine neurons following 7-day withdrawal from chronic cocaine abuse is normalized by D2 receptor stimulation during the early withdrawal phase.
Topics: Animals; Apomorphine; Benzazepines; Cocaine-Related Disorders; Dopamine; Dopamine Agonists; Dopamine Antagonists; Electrophysiology; Male; Mesencephalon; Neurons; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Substance Withdrawal Syndrome; Substantia Nigra; Ventral Tegmental Area | 1999 |
Going from the bedside back to the bench with ecopipam: a new strategy for cocaine pharmacotherapy development.
Topics: Benzazepines; Cocaine-Related Disorders; Dopamine Antagonists; Humans; Research Design | 2001 |